Cargando…

Metabolic and Proteomic Profiles Associated with Immune Responses Induced by Different Inactivated SARS-CoV-2 Vaccine Candidates

Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in late 2019, the virus has been mutating continuously, resulting in the continuous emergence of variants and creating challenges for epidemic prevention and control. Here, we immunized mice with different vaccine ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Shouzhi, He, Yao, Ji, Wenheng, Yang, Rong, Zhao, Yuxiu, Li, Yan, Liu, Yingwei, Ding, Ling, Ma, Meng, Wang, Hui, Yang, Xiaoming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503298/ https://www.ncbi.nlm.nih.gov/pubmed/36142558 http://dx.doi.org/10.3390/ijms231810644

Ejemplares similares

Comparison of Physical and Biochemical Characterizations of SARS-CoV-2 Inactivated by Different Treatments
por: Yu, Shouzhi, et al.
Publicado: (2022)

Correction: Yu et al. Comparison of Physical and Biochemical Characterizations of SARS-CoV-2 Inactivated by Different Treatments. Viruses 2022, 14, 1938
por: Yu, Shouzhi, et al.
Publicado: (2023)

Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
por: Wang, Hui, et al.
Publicado: (2020)

Development of an inactivated vaccine candidate for SARS-CoV-2
por: Gao, Qiang, et al.
Publicado: (2020)

Alum/CpG Adjuvanted Inactivated COVID-19 Vaccine with Protective Efficacy against SARS-CoV-2 and Variants
por: Zhang, Yuntao, et al.
Publicado: (2022)

Immunogenicity Evaluating of the Multivalent COVID-19 Inactivated Vaccine against the SARS-CoV-2 Variants
por: Zhang, Yuntao, et al.
Publicado: (2022)

Vaccination with Omicron Inactivated Vaccine in Pre-vaccinated Mice Protects against SARS-CoV-2 Prototype and Omicron Variants
por: Zhang, Yuntao, et al.
Publicado: (2022)

Biochemical and antigenic characterization of the structural proteins and their post-translational modifications in purified SARS-CoV-2 virions of an inactivated vaccine candidate
por: Zhang, Xiao-Yu, et al.
Publicado: (2020)

Preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates
por: Sir Karakus, Gozde, et al.
Publicado: (2021)

The Effect of Inactivated SARS-CoV-2 Vaccines on TRAB in Graves’ Disease
por: Huang, LingHong, et al.
Publicado: (2022)

Inactivated vaccine for SARS-CoV-2
por: Risson, Emma
Publicado: (2020)

Safety and immunogenicity of a combined DTacP-sIPV-Hib vaccine in animal models
por: Zhang, Yuntao, et al.
Publicado: (2022)

Physicochemical properties and adsorption state of aluminum adjuvants with different processes in vaccines
por: Bo, Cunpei, et al.
Publicado: (2023)

Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques
por: Yadav, Pragya D., et al.
Publicado: (2021)

Immunological Study of Combined Administration of SARS-CoV-2 DNA Vaccine and Inactivated Vaccine
por: Meng, Ziyan, et al.
Publicado: (2022)

Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine
por: Duarte, Luisa F., et al.
Publicado: (2021)

Metabolic Responses and Pathway Changes of Vero Cells under High-Vitamin B Medium
por: Yu, Shouzhi, et al.
Publicado: (2022)

Effectiveness of an Inactivated SARS-CoV-2 Vaccine
por: Wilder-Smith, Annelies, et al.
Publicado: (2021)

Inactivated Vaccines Against SARS-CoV-2: Neutralizing Antibody Titers in Vaccine Recipients
por: Zhang, Haiying, et al.
Publicado: (2022)

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
por: Xia, Shengli, et al.
Publicado: (2021)

Immunological evaluation of an inactivated SARS-CoV-2 vaccine in rhesus macaques
por: Chen, Hongbo, et al.
Publicado: (2021)

Proteomic and Metabolomic Signatures Associated With the Immune Response in Healthy Individuals Immunized With an Inactivated SARS-CoV-2 Vaccine
por: Wang, Yi, et al.
Publicado: (2022)

Radiation-Inactivated Acinetobacter baumannii Vaccine Candidates
por: Dollery, Stephen J., et al.
Publicado: (2021)

Development of an Inactivated Vaccine against SARS CoV-2
por: Pavel, Shaikh Terkis Islam, et al.
Publicado: (2021)

Inactivated SARS-CoV-2 vaccine for people with HIV
por: Wolday, Dawit, et al.
Publicado: (2022)

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile
por: Jara, Alejandro, et al.
Publicado: (2021)

Sars-cov-2-vaccine-inactivated: Encephalopathy: case report
Publicado: (2022)

Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine
por: Zhou, Xingdong, et al.
Publicado: (2021)

Poor Response to Inactivated SARS-CoV-2 Vaccine in Patients With Chronic Liver Disease
por: Cao, Huanhuan, et al.
Publicado: (2022)

Immune response profiles of calves following vaccination with live BCG and inactivated Mycobacterium bovis vaccine candidates
por: van der Heijden, E. M. D. L., et al.
Publicado: (2017)

Safety of inactivated SARS-CoV-2 vaccines in patients with allergic diseases
por: Cao, Chao, et al.
Publicado: (2022)

Immunogenicity profiling and distinct immune response in liver transplant recipients vaccinated with SARS-CoV-2 inactivated vaccines
por: Duan, Binwei, et al.
Publicado: (2022)

SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients
por: Deng, Yao, et al.
Publicado: (2021)

Preparation, characterization and preliminary in vivo studies of inactivated SARS-CoV vaccine
por: Tang, Lin, et al.
Publicado: (2003)

Systematic profiling of SARS-CoV-2-specific IgG responses elicited by an inactivated virus vaccine identifies peptides and proteins for predicting vaccination efficacy
por: Ma, Ming-Liang, et al.
Publicado: (2021)

Omicron SARS-CoV-2 Neutralization from Inactivated and ZF2001 Vaccines
por: Zhao, Xin, et al.
Publicado: (2022)

Immunological evaluation of an mRNA vaccine booster in individuals fully immunized with an inactivated SARS‐CoV‐2 vaccine
por: Xu, Xingli, et al.
Publicado: (2022)

Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model
por: Mohandas, Sreelekshmy, et al.
Publicado: (2021)

Development of DNA Vaccine Candidate against SARS-CoV-2
por: Wang, Xingyun, et al.
Publicado: (2022)

A protein subunit vaccine booster following two doses of inactivated SARS-CoV-2 vaccine provides high neutralisation of SARS-CoV-2 and its variants in mice
por: Zhang, Rong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dh5j3i4ln2qup0t88ajd4okpkg